Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBL 2018
NCT04043494Phase 3Recruiting
- Sponsor
- Universitätsklinikum Münster
- Start
- Aug 2019
- Primary completion
- Apr 2030
- Modality
- Orthosteric Ligands
- Countries
- 21
01
Overview
A Phase 3 trial of dexamethasone in lymphoblastic lymphoma (LL), sponsored by Universitätsklinikum Münster. Started Aug 2019; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT04043494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043494.